Risk of side effects from cancer immunotherapy linked to genetics
MedicalXpress Breaking News-and-Events | Dec 20, 2022
FDA approves “glowing tumor” imaging drug to aid lung cancer surgery
Newswise | Dec 20, 2022
Novel subtype of nasopharyngeal carcinoma and Epstein-Barr virus–associated immune suppression discovered
MedicalXpress Breaking News-and-Events | Dec 17, 2022
New targets in the fight against pancreatic cancer
MedicalXpress Breaking News-and-Events | Dec 17, 2022
Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target
MedicalXpress Breaking News-and-Events | Dec 17, 2022
Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer
MedicalXpress Breaking News-and-Events | Dec 16, 2022
Computational method used to directly measure tumors shows hypertranscription is ubiquitous across cancers
MedicalXpress Breaking News-and-Events | Dec 16, 2022
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer
MedicalXpress Breaking News-and-Events | Dec 15, 2022
Point-of-care biosensor rapidly detects oral cancer
MedicalXpress Breaking News-and-Events | Dec 15, 2022
Possible therapeutic approach to fight incurable blood cancer
MedicalXpress Breaking News-and-Events | Dec 14, 2022